Kanako Yajima
Overview
Explore the profile of Kanako Yajima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koshika K, Hashimoto W, Nakakuki A, Yajima K, Ichinohe T
J Dent Anesth Pain Med
. 2025 Feb;
25(1):33-42.
PMID: 39944849
Background: Video laryngoscopy is beneficial in difficult airway intubation; however, various factors complicate the process. These devices come in different designs, and their usefulness may vary by type. In this...
2.
Murayama N, Yajima K, Hikawa M, Shimura K, Ishii Y, Takada M, et al.
Biopharm Drug Dispos
. 2017 Nov;
39(2):116-121.
PMID: 29136681
The fraction of substrate metabolized (f ) can be used to estimate drug interactions and can be determined by comparison of the intrinsic clearances (CL ) of victim drugs obtained...
3.
Yajima K, Uno Y, Murayama N, Uehara S, Shimizu M, Nakamura C, et al.
Drug Metab Dispos
. 2014 Feb;
42(5):867-71.
PMID: 24553381
Due to the importance of in vitro cytochrome P450 (P450) induction assay to assess the possible drug-drug interaction events, the recent US Food and Drug Administration draft guidance and European...
4.
Murayama N, van Beuningen R, Suemizu H, Guillouzo C, Shibata N, Yajima K, et al.
Chem Res Toxicol
. 2014 Jan;
27(2):304-308.
PMID: 24460184
Heterotropic cooperativity of human cytochrome P450 (P450) 3A4/3A5 by the teratogen thalidomide was recently demonstrated by H. Yamazaki et al. ( ( 2013 ) Chem. Res. Toxicol. 26 , 486...
5.
Yamatoya H, Kawaguchi H, Yajima K, Kadokura H, Yoshikawa T, Yamashita R, et al.
Exp Anim
. 2012 Aug;
61(4):467-76.
PMID: 22850647
The aim of this study was to collect data on chronological changes in clinical laboratory tests, pathological examinations, and hepatic drug-metabolizing enzymes from Wistar Hannover rats at 8, 10, 19,...
6.
Takusagawa S, Yajima K, Miyashita A, Uehara S, Iwatsubo T, Usui T
Xenobiotica
. 2012 Apr;
42(10):957-67.
PMID: 22509825
1. Human cytochrome P450 (CYP) enzymes and esterases involved in the metabolism of mirabegron, a potent and selective human β(3)-adrenoceptor agonist intended for the treatment of overactive bladder, were identified...
7.
Shiraga T, Yajima K, Teragaki T, Suzuki K, Hashimoto T, Iwatsubo T, et al.
Biol Pharm Bull
. 2012 Mar;
35(3):413-21.
PMID: 22382330
Darexaban maleate is a novel oral direct factor Xa inhibitor. Darexaban glucuronide (YM-222714) was the major component in plasma after oral administration of darexaban to humans and is the pharmacologically...
8.
Shiraga T, Yajima K, Suzuki K, Suzuki K, Hashimoto T, Iwatsubo T, et al.
Drug Metab Dispos
. 2011 Oct;
40(2):276-82.
PMID: 22031623
Darexaban maleate is a novel oral direct factor Xa inhibitor, which is under development for the prevention of venous thromboembolism. Darexaban glucuronide was the major component in plasma after oral...
9.
Hirata-Koizumi M, Matsuno K, Kawabata M, Yajima K, Matsuyama T, Hirose A, et al.
Drug Chem Toxicol
. 2009 Jun;
32(3):204-14.
PMID: 19538016
Previously, we showed that the toxic susceptibility of male rats to an ultraviolet absorber, 2-(2'-hydroxy- 3',5'-di-tert-butylphenyl)benzotriazole (HDBB), was nearly 25 times higher than that of females. The present study aimed...
10.
Fukazawa T, Yajima K, Miyamoto Y
Yakugaku Zasshi
. 2008 Oct;
128(10):1459-65.
PMID: 18827466
Beraprost sodium (BPS), a chemically stable and orally active prostacyclin analogue used for the treatment of chronic occlusive disease and primary pulmonary hypertension, was investigated in terms of its drug-drug...